RAPGEF2 levels in 12‐month‐old mutants also showed an increasing trend without statistical significance, possibly due to the high variability of RAPGEF2 levels in older 3xTg‐AD mice (Figure S2 ).
← all excerpts
RAPGEF2 mediates oligomeric Aβ-induced synaptic loss and cognitive dysfunction in the 3xTg-AD mouse model of Alzheimer's disease.
1
—
—